Exercise training improves endothelial function via adiponectin-dependent and independent pathways in type 2 diabetic mice

Am J Physiol Heart Circ Physiol. 2011 Aug;301(2):H306-14. doi: 10.1152/ajpheart.01306.2010. Epub 2011 May 20.

Abstract

Type 2 diabetes (T2D) is a leading risk factor for a variety of cardiovascular diseases including coronary heart disease and atherosclerosis. Exercise training (ET) has a beneficial effect on these disorders, but the basis for this effect is not fully understood. This study was designed to investigate whether the ET abates endothelial dysfunction in the aorta in T2D. Heterozygous controls (m Lepr(db)) and type 2 diabetic mice (db/db; Lepr(db)) were either exercise entrained by forced treadmill exercise or remained sedentary for 10 wk. Ex vivo functional assessment of aortic rings showed that ET restored acetylcholine-induced endothelial-dependent vasodilation of diabetic mice. Although the protein expression of endothelial nitric oxide synthase did not increase, ET reduced both IFN-γ and superoxide production by inhibiting gp91(phox) protein levels. In addition, ET increased the expression of adiponectin (APN) and the antioxidant enzyme, SOD-1. To investigate whether these beneficial effects of ET are APN dependent, we used adiponectin knockout (APNKO) mice. Indeed, impaired endothelial-dependent vasodilation occurred in APNKO mice, suggesting that APN plays a central role in prevention of endothelial dysfunction. APNKO mice also showed increased protein expression of IFN-γ, gp91(phox), and nitrotyrosine but protein expression of SOD-1 and -3 were comparable between wild-type and APNKO. These findings in the aorta imply that APN suppresses inflammation and oxidative stress in the aorta, but not SOD-1 and -3. Thus ET improves endothelial function in the aorta in T2D via both APN-dependent and independent pathways. This improvement is due to the effects of ET in inhibiting inflammation and oxidative stress (APN-dependent) as well as in improving antioxidant enzyme (APN-independent) performance in T2D.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adiponectin / blood
  • Adiponectin / genetics
  • Adiponectin / metabolism
  • Analysis of Variance
  • Animals
  • Aorta / drug effects
  • Aorta / metabolism*
  • Aorta / physiopathology
  • Diabetes Mellitus, Type 2 / genetics
  • Diabetes Mellitus, Type 2 / metabolism
  • Diabetes Mellitus, Type 2 / physiopathology*
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / metabolism*
  • Endothelium, Vascular / physiopathology
  • Inflammation Mediators / metabolism
  • Interferon-gamma / metabolism
  • Male
  • Membrane Glycoproteins / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • NADPH Oxidase 2
  • NADPH Oxidases / metabolism
  • Nitric Oxide / metabolism
  • Oxidative Stress
  • Physical Exertion*
  • Signal Transduction* / drug effects
  • Superoxide Dismutase / metabolism
  • Superoxide Dismutase-1
  • Superoxides / metabolism
  • Time Factors
  • Tyrosine / analogs & derivatives
  • Tyrosine / metabolism
  • Vasodilation* / drug effects
  • Vasodilator Agents / pharmacology

Substances

  • Adiponectin
  • Adipoq protein, mouse
  • Inflammation Mediators
  • Membrane Glycoproteins
  • Vasodilator Agents
  • Superoxides
  • Nitric Oxide
  • 3-nitrotyrosine
  • Tyrosine
  • Interferon-gamma
  • Sod1 protein, mouse
  • Sod3 protein, mouse
  • Superoxide Dismutase
  • Superoxide Dismutase-1
  • Cybb protein, mouse
  • NADPH Oxidase 2
  • NADPH Oxidases